Sean Dodge
Stock Analyst at BMO Capital
(0.24)
# 4,467
Out of 4,651 analysts
504
Total ratings
43.2%
Success rate
-3.6%
Average return
Main Sectors:
Stocks Rated by Sean Dodge
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AVAH Aveanna Healthcare Holdings | Reiterated: Buy | $10 → $14 | $12.32 | +13.64% | 4 | Aug 14, 2026 | |
| PRVA Privia Health Group | Maintained: Buy | $30 | $22.00 | +36.36% | 18 | Aug 7, 2026 | |
| EVH Evolent Health | Maintained: Buy | $6 | $4.68 | +28.21% | 54 | Aug 6, 2026 | |
| SHC Sotera Health Company | Rated: Buy | $20 → $22 | $18.89 | +16.46% | 29 | Aug 6, 2026 | |
| LFST LifeStance Health Group | Rated: Buy | $11 → $13 | $12.42 | +4.67% | 5 | Aug 6, 2026 | |
| DOCS Doximity | Rated: Hold | $20 → $30 | $24.80 | +20.97% | 4 | Aug 6, 2026 | |
| OMDA Omada Health | Rated: Buy | $20 → $24 | $24.04 | -0.17% | 4 | Aug 6, 2026 | |
| MDLN Medline | Rated: Buy | $54 → $47 | $35.74 | +31.51% | 3 | Aug 5, 2026 | |
| ADUS Addus HomeCare | Maintained: Hold | $110 → $115 | $116.06 | -0.91% | 5 | Aug 4, 2026 | |
| CERT Certara | Maintained: Hold | $6 → $8 | $8.00 | - | 4 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 | $61.71 | +13.43% | 6 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $210 → $270 | $236.66 | +14.09% | 14 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $5 → $7 | $6.81 | +2.79% | 56 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $30 | $24.78 | +21.07% | 12 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $600 | $578.50 | +3.72% | 5 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $24 | $21.59 | +11.16% | 54 | Jul 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $160 → $187 | $163.15 | +14.62% | 9 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $12.28 | +14.01% | 31 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $220 → $175 | $243.75 | -28.21% | 4 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $85 → $105 | $104.73 | +0.26% | 33 | Apr 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $3.73 | n/a | 30 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $6 | $1.85 | n/a | 22 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 → $3.5 | $96.90 | n/a | 18 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $7 → $6 | $8.72 | n/a | 23 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $4.90 | n/a | 30 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 | $0.0001 | n/a | 13 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $6.22 | n/a | 1 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8.5 → $7 | $0.9509 | n/a | 11 | Feb 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $135 | $234.32 | n/a | 1 | May 19, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $869.00 | n/a | 1 | Aug 2, 2010 |
Aveanna Healthcare Holdings
Aug 14, 2026
Reiterated: Buy
Price Target: $10 → $14
Current: $12.32
Upside: +13.64%
Privia Health Group
Aug 7, 2026
Maintained: Buy
Price Target: $30
Current: $22.00
Upside: +36.36%
Evolent Health
Aug 6, 2026
Maintained: Buy
Price Target: $6
Current: $4.68
Upside: +28.21%
Sotera Health Company
Aug 6, 2026
Rated: Buy
Price Target: $20 → $22
Current: $18.89
Upside: +16.46%
LifeStance Health Group
Aug 6, 2026
Rated: Buy
Price Target: $11 → $13
Current: $12.42
Upside: +4.67%
Doximity
Aug 6, 2026
Rated: Hold
Price Target: $20 → $30
Current: $24.80
Upside: +20.97%
Omada Health
Aug 6, 2026
Rated: Buy
Price Target: $20 → $24
Current: $24.04
Upside: -0.17%
Medline
Aug 5, 2026
Rated: Buy
Price Target: $54 → $47
Current: $35.74
Upside: +31.51%
Addus HomeCare
Aug 4, 2026
Maintained: Hold
Price Target: $110 → $115
Current: $116.06
Upside: -0.91%
Certara
Aug 4, 2026
Maintained: Hold
Price Target: $6 → $8
Current: $8.00
Upside: -
Aug 3, 2026
Maintained: Buy
Price Target: $70
Current: $61.71
Upside: +13.43%
Jul 29, 2026
Maintained: Buy
Price Target: $210 → $270
Current: $236.66
Upside: +14.09%
Jul 29, 2026
Rated: Hold
Price Target: $5 → $7
Current: $6.81
Upside: +2.79%
Jul 29, 2026
Rated: Buy
Price Target: $30
Current: $24.78
Upside: +21.07%
Jul 27, 2026
Maintained: Hold
Price Target: $600
Current: $578.50
Upside: +3.72%
Jul 22, 2026
Reiterated: Hold
Price Target: $24
Current: $21.59
Upside: +11.16%
Jun 25, 2026
Maintained: Buy
Price Target: $160 → $187
Current: $163.15
Upside: +14.62%
Jun 22, 2026
Maintained: Buy
Price Target: $14
Current: $12.28
Upside: +14.01%
Jun 3, 2026
Maintained: Hold
Price Target: $220 → $175
Current: $243.75
Upside: -28.21%
Apr 9, 2026
Upgraded: Buy
Price Target: $85 → $105
Current: $104.73
Upside: +0.26%
Feb 27, 2025
Maintained: Buy
Price Target: $6
Current: $3.73
Upside: n/a
Feb 26, 2025
Maintained: Hold
Price Target: $7 → $6
Current: $1.85
Upside: n/a
Feb 25, 2025
Maintained: Buy
Price Target: $3 → $3.5
Current: $96.90
Upside: n/a
Jan 8, 2025
Downgraded: Hold
Price Target: $7 → $6
Current: $8.72
Upside: n/a
Mar 13, 2024
Maintained: Buy
Price Target: $11
Current: $4.90
Upside: n/a
May 11, 2022
Maintained: Hold
Price Target: $2
Current: $0.0001
Upside: n/a
Nov 10, 2021
Reiterated: Buy
Price Target: $16
Current: $6.22
Upside: n/a
Feb 20, 2019
Reiterated: Hold
Price Target: $8.5 → $7
Current: $0.9509
Upside: n/a
May 19, 2017
Reiterated: Sell
Price Target: $135
Current: $234.32
Upside: n/a
Aug 2, 2010
Reiterated: Buy
Price Target: n/a
Current: $869.00
Upside: n/a